THE DRUG RESISTANCE MUTATIONS OF THE HEPATITIS B VIRUS AMONG HIV-INFECTED INDIVIDUALS

Código QR

THE DRUG RESISTANCE MUTATIONS OF THE HEPATITIS B VIRUS AMONG HIV-INFECTED INDIVIDUALS

.

Guardado en:

Detalles Bibliográficos
Autor principal:	Yu. V. Ostankova
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/d18f5dc30dcc45e3a62b92b30b98e9c3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
por: D. E. Valutite, et al.
Publicado: (2018)

THE PREVALENCE OF HIV-1 DRUG RESISTANCE MUTATIONS IN PATIENTS WITH LOW ADHERENCE TO ANTIRETROVIRAL THERAPY IN THE LENINGRAD REGION
por: A. N. Shchemelev, et al.
Publicado: (2018)

HEPATITIS B VIRUS IDENTIFICATION IN THE ENSURING INFECTIOUS SAFETY OF BLOOD TRANSFUSIONS
por: Yu. V. Ostankova, et al.
Publicado: (2018)

FREQUENCY AND THE CLINICAL SIGNIFICANCE OF OCCULT HEPATITIS B VIRUS INFECTION
por: E. V. Esaulenko, et al.
Publicado: (2018)

THE SIGNIFICANCE OF THE HIV RESISTANCE ANALYSIS IN ANTIRETROVIRAL THERAPY
por: D. E. Valutite, et al.
Publicado: (2018)

HEPATITIS A PREVALENCE AMONG CHILDREN IN BOKE AND KINDIA PROVINCES (REPUBLIC OF GUINEA)
por: E. V. Esaulenko, et al.
Publicado: (2018)

Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya
por: Martin O. Ogwang, et al.
Publicado: (2021)

EPIDEMIOLOGICAL CHARACTERISTICS OF INCIDENCE OF CHRONIC VIRAL HEPATITIS B INFECTION AMONG HEALTHCARE WORKERS IN ST. PETERSBURG IN 2013–2017
por: D. V. Vasilyev, et al.
Publicado: (2018)

THE ANALYSIS OF TRANSMITTED HIV-1 VARIANTS AMONG ACUTELY INFECTED PEOPLE WHO INJECT DRUGS USING NGS APPROACH
por: E. Akulova, et al.
Publicado: (2018)

Prevalence of HIV, Hepatitis C and its related risk behaviours among women who inject drugs in the Kathmandu Valley, Nepal: a cross-sectional study
por: José Damas, et al.
Publicado: (2021)

MYCOBACTERIUM TUBERCULOSIS DRUG RESISTANCE MUTATIONS AND UNDERSTANDING OF PK/PD: TREATMENT AND CARE IMPLICATIONS
por: S. K. Heysell, et al.
Publicado: (2018)

Knowledge and Awareness of Hepatitis B Virus Infection in Nigeria
por: Angela O. Eni, et al.
Publicado: (2019)

Investigation of Drug-resistance substitutions in HIV-1 RT Protein in Iranian HIV Infected Patients
por: Behzad non Dehghani, et al.
Publicado: (2019)

SENSITIVITY OF 2018 KAZAKHSTAN INFLUENZA TYPE B VIRUSES TO ANTIVIRAL DRUGS
por: G. V. Lukmanova, et al.
Publicado: (2018)

LOW HEPATITIS B VIRUS DNA BURDEN DOES NOT ALWAYS PROTECT FROM LIVER CANCER DEVELOPMENT
por: P. Pineau
Publicado: (2018)

PHYSIOLOGICAL IMPACT OF THE EVOLUTION OF THE rpoB MUTATION
por: M. Grobbelaar, et al.
Publicado: (2018)

RISK FACTORS OF PERINATAL TRANSMISSION OF HEPATITIS C VIRUS
por: T. V. Znovets, et al.
Publicado: (2018)

IDENTIFICATION OF MUTATIONS OF RESISTANCE TO FLUOROQUINOLONES, AMINOGLYCOSIDES AND ETHAMBUTOL IN RIFAMPICIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS
por: I. V. Bakshtanovskaya, et al.
Publicado: (2018)

RESULTS OF GENOTYPING HEPATITIS VIRUS B IN HBsAg-NEGATIVE BLOOD DONORS IN ASTANA, KAZAKHSTAN
por: Yu. V. Ostankova, et al.
Publicado: (2018)

Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection
por: Elvira Baos, et al.
Publicado: (2022)

VIRAL HEPATITIS B AND C IN THE ARKHANGELSK REGION: LONG-TERM DYNAMICS OF INCIDENCE AND CROSS-SECTIONAL STUDY OF MARKERS AMONG ADULT POPULATION
por: T. V. Balaeva, et al.
Publicado: (2018)

MONITORING OF LONG-TERM ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS B
por: A. A. Sukhoruk, et al.
Publicado: (2018)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Anna L McNaughton, et al.
Publicado: (2021)

ANTIBIOTIC-RESISTANT KLEBSIELLA PNEUMONIAE IN THE GUT MICROBIOTA OF HEALTHY INDIVIDUALS
por: E. V. Voitenkova, et al.
Publicado: (2018)

MOLECULAR-GENETIC CHARACTERISTICS OF THE HEPATITIS B IN THE NANAYSKY DISTRICT OF THE KHABAROVSK TERRITORY
por: V. O. Kotova, et al.
Publicado: (2018)

Prevalence and molecular-genetic characteristics of hepatitis B virus in HIV-positive individuals at the Far Eastern Federal District
por: E. A. Bazykina, et al.
Publicado: (2019)

THE CORRELATION BETWEEN LEVELS OF PHENOTYPIC RESISTANCE AND GENOTYPIC MUTATIONS OF M. TUBERCULOSIS
por: N. Ciobanu, et al.
Publicado: (2018)

Developing human capital in clinical research: Impact on reducing transfusion-transmitted HIV and hepatitis virus infections in Africa
por: Edward L. Murphy, et al.
Publicado: (2016)

FEATURES OF THE SUBPOPULATION COMPOSITION CYTOTOXIC T-LYMPHOCYTES IN CHILDREN WITH CONGENITAL CHRONIC HEPATITIS B
por: O. K. Batsunov, et al.
Publicado: (2018)

GENETIC DIVERSITY AND DRUG RESISTANCE OF MYCOBACTERIUM AVIUM IN ITALY
por: f. Genua, et al.
Publicado: (2018)

HIGH BURDEN OF HEPATITIS B IN VIETNAM: IMPACT OF A HIGHLY HETEROGENEOUS VIRAL POPULATION
por: O. V. Kalinina, et al.
Publicado: (2018)

DRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: FROM PHENOTYPIC MIC-ANALYSIS TO WGS FOR ROUTINE DRUG SUSCEPTIBILITY TESTING
por: J. Werngren
Publicado: (2018)

WGS IN ROUTINE DIAGNOSTICS OF TUBERCULOSIS — PREDICTION OF DRUG RESISTANCE AND GENOTYPING
por: H. Soini
Publicado: (2018)

ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
por: I. V. Peretokina, et al.
Publicado: (2018)

RECONSTRUCTION OF RECOMBINATION SITES IN GENOMES OF GENOTYPE 2 HEPATITIS C VIRUS STRAINS USING BIOINFORMATICS METHODS
por: A. I. Paramonov, et al.
Publicado: (2018)

CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
por: A. Budkowska
Publicado: (2018)

NEW METHOD FOR DETERMINING HEPATITIS B VIRUS RESISTANCE MUTATIONS M204I/V TO NUCLEOS(T)IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B
por: E. A. Elpaeva, et al.
Publicado: (2015)

ANALYSIS OF GENE MUTATIONS ASSOCIATED WITH MDR AMONG MYCOBACTERIUM TUBERCULOSIS STRAINS ISOLATED IN MOSCOW REGION
por: M. Alvarez Figueroa, et al.
Publicado: (2018)

GENETIC VARIANTS OF HEPATITIS B VIRUS IN PRIMARY DONORS IN ASTANA, KAZAKHSTAN
por: Yu. V. Ostankova, et al.
Publicado: (2017)

DETECTION OF PARVOVIRUS INFECTION MARKERS IN RISK GROUPS
por: I. V. Khamitova, et al.
Publicado: (2018)